Fast Five Quiz: Stroke Prevention in Atrial Fibrillation

Brian Silver, MD


September 10, 2019

Oral anticoagulation is the therapy of choice for primary stroke prevention in patients with AFib and one additional major risk factor or two additional minor risk factors, and secondary stroke prevention for patients with AFib (no additional risk factors necessary in addition to stroke). Asymptomatic patients < 65 years with AFib and none of the other risk factors are at a low risk and do not require treatment with medications.

For more information about anticoagulation in patients with AFib, go here.

Follow Medscape on Facebook, Twitter, Instagram, and YouTube


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: